Anti-Amyloid Beta Antibody (Crenezumab)
Catalog No.
F1532
Anti-Amyloid Beta Antibody (Crenezumab)
Featured Products
Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds to multiple forms of Aβ, such as soluble, oligomeric, and fibrillar, and is used in Alzheimer's disease research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
143.58 kDa
Dry ice
1095207-05-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Anti-Abeta, MABT5102A, RG7412
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P05067
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Amyloid Beta
Please avoid freeze-thaw cycles.